Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

Blood (2019) 134 (3): 252–262.

https://doi.org/10.1182/blood.2019000633

Published: 2019

Includes: Supplemental data

Journal Articles

Antisense Oligonucleotide Targeting of Thrombopoietin Synthesis Reduces Platelet Count within the Hemostatic Range and Slows Progression of De Novo Mammary Carcinogenesis in the Mmtv-Pymt Mouse

Toshiaki Shirai, PhD, Alexey Revenko, PhD, Justin Tibbits, MS, Lisa M Coussens, PhD, Owen JT McCarty, PhD, Brett P. Monia, PhD, Andras Gruber, MD

Blood (2018) 132 (Supplement 1): 989.

https://doi.org/10.1182/blood-2018-99-114157

Published: 2018

Journal Articles

Highly Multiplexed Imaging Mass Cytometry Allows Visualization of Tumor and Immune Cell Interactions of the Tumor Microenvironment in FFPE Tissue Sections

Mohan Singh, PhD, Parvesh Chaudhry, PhD, Erik Gerdtsson, MS, Asaf Maoz, MD, Wendy Cozen, DO,MPH, James Hicks, PhD, Peter Kuhn, PhD, Stephen Gruber, MD PhD MPH, Imran Siddiqi, MDPhD, Akil Merchant, MD

Blood (2017) 130 (Supplement 1): 2751.

https://doi.org/10.1182/blood.V130.Suppl_1.2751.2751

Published: 2017

Journal Articles

Regulation of the Tumor Microenvironment By High Molecular Weight Kininogen

Meenal Shukla, PhD, Venkaiah Betapudi, PhD, Ravi Kumar Alluri, PhD, Sergei Merkulov, PhD, James Hale, PhD, Justin Lathia, PhD, Keith R. McCrae, MD

Blood (2016) 128 (22): 1394.

https://doi.org/10.1182/blood.V128.22.1394.1394

Published: 2016

Journal Articles

Treatment of Hodgkin Lymphoma Xenografts with the Novel PI3K δ/γ Inhibitor RP6530 Suppresses M2 Macrophage Polarization and Results in Potent Antitumor and Antiangiogenic Effects

Silvia Laura Locatelli, PhD, Francesca Maria Consonni, Giuseppa Careddu, Simone Serio, Srikant Viswanadha, PhD, Swaroop Vakkalanka, PhD, Luca Castagna, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD

Blood (2016) 128 (22): 45.

https://doi.org/10.1182/blood.V128.22.45.45

Published: 2016

Journal Articles

Relationship of Baseline Tumor Angiogenesis with Kinetics of Inflammatory Markers in DLBCL

Gaurav Prakash, MD DM, Vaishali Aggarwal, Nidhi Jain, MD, Amanjit Bal, MD, Manupdesh Singh Sachdeva, MD, Pankaj Malhotra, MD MBBS, Alka Khadwal, MD, Vikas Suri, MD, Savita Kumari, MD DM, Ashim Das, MD, Subhash Varma, MBBS, MD Professor & Head, Sub Dean

Blood (2015) 126 (23): 5056.

https://doi.org/10.1182/blood.V126.23.5056.5056

Published: 2015

Journal Articles

Synergistic Induction of Cell Death in Hodgkin Lymphoma Cells By the Novel PI3K Inhibitor RP6530 Combined with Brentuximab Vedotin (SGN-35) through Inhibition of Tumor Angiogenesis

Silvia Laura Locatelli, PhD, Giuseppa Careddu, Armando Chierchia, Srikant Viswanadha, PhD, Swaroop Vakkalanka, PhD, Luca Castagna, Armando Santoro, MD, Carmelo Carlo-Stella, MD

Blood (2015) 126 (23): 1561.

https://doi.org/10.1182/blood.V126.23.1561.1561

Published: 2015

Journal Articles

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans

Alexander T. Bauer, Jan Suckau, Kathrin Frank, Anna Desch, Lukas Goertz, Andreas H. Wagner, Markus Hecker, Tobias Goerge, Ludmila Umansky, Philipp Beckhove, Jochen Utikal, Christian Gorzelanny, Nancy Diaz-Valdes, Viktor Umansky, Stefan W. Schneider

Blood (2015) 125 (20): 3153–3163.

https://doi.org/10.1182/blood-2014-08-595686

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

KB004, a Novel Non-Fucosylated Humaneered® Antibody, Targeting EphA3, Is Active and Well Tolerated in a Phase I/II Study of Advanced Hematologic Malignancies

Ronan T Swords, MD PhD FRCPI, FRCPath, Andrew H Wei, MBBS, PhD, Simon Durrant, MBBS, MRCS, LRCP, FRCP, FRCPat, Anjali S. Advani, MD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, Ian D Lewis, MBBS, PhD, Peter L. Greenberg, MD PhD, Jorge E. Cortes, MD, Geoff T Yarranton, PhD, Jackie M. Walling, MBChB, PhD, Jeffrey E. Lancet, MD

Blood (2014) 124 (21): 3756.

https://doi.org/10.1182/blood.V124.21.3756.3756

Published: 2014

Journal Articles

Non Pegylated Liposomal Doxorubicin in Combination with Dexamethasone and Lenalidomide (RMD) Is Active in Advanced MM

Gabriele Buda, MD, Enrico Orciuolo, Martina Rousseau, Sara Galimberti, Nadia Cecconi, Mario Petrini, MD

Blood (2014) 124 (21): 5742.

https://doi.org/10.1182/blood.V124.21.5742.5742

Published: 2014

Journal Articles

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Christoph Schliemann, MD, Katrin Gutbrodt, PhD, Andrea Kerkhoff, MD, Michele Pohlen, MD, Stefanie Wiebe, MD, Gerda Silling, MD, Linus Angenendt, Torsten Kessler, MD, Rolf M Mesters, MD, Leonardo Giovannoni, PhD, Michael Schäfers, MD, Bianca Altvater, PhD, Claudia Rössig, MD, Inga Grünewald, MD, Eva Wardelmann, MD, Gabriele Köhler, MD, Dario Neri, PhD, Matthias Stelljes, MD, Wolfgang E Berdel, MD

Blood (2014) 124 (21): 980.

https://doi.org/10.1182/blood.V124.21.980.980

Published: 2014

Journal Articles

Potent Effects Of The Vascular Disrupting Agent, ASA404 (DMXAA) On The Marrow Microenvironment In Preclinical Human Leukemia and Lymphoma Models

Scott Portwood, M.S., Deepika Lal, M.S., Christopher W Schaefer, M.S., Odochi Uwazurike, B.S., Joseph A Spernyak, PhD, Mukund Seshadri, PhD, Eunice S. Wang, MD

Blood (2013) 122 (21): 3953.

https://doi.org/10.1182/blood.V122.21.3953.3953

Published: 2013

Journal Articles

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

Jeffrey E Lancet, MD, Andrew H Wei, MBBS, PhD, Simon TS Durrant, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Ian D Lewis, MB, BS, PhD, Brian Jonas, MD, PhD, Jorge E. Cortes, MD, Geoffrey Yarranton, PhD, Jackie M. Walling, MBChB, PhD

Blood (2013) 122 (21): 3838.

https://doi.org/10.1182/blood.V122.21.3838.3838

Published: 2013

Journal Articles

ADAMTS13 Expressed In Glioblastoma and Astrocytoma Cells Can Modulate Endothelial Cell Migration

Manfai Lee, PhD, Courtney Hoyt, George M Rodgers, MD, PhD

Blood (2013) 122 (21): 2306.

https://doi.org/10.1182/blood.V122.21.2306.2306

Published: 2013

Journal Articles

SOX11 Regulates Angiogenesis In Mantle Cell Lymphoma

Jara Palomero, Maria Carmela Vegliante, Marta Rodríguez, Ester Planas, Inmaculada Ribera, MD, Maria Cinta Cid, MD, PhD, Elias Campo, MD, PhD, Virginia Amador, PhD

Blood (2013) 122 (21): 246.

https://doi.org/10.1182/blood.V122.21.246.246

Published: 2013

Journal Articles

Pericytes promote selective vessel regression to regulate vascular patterning

Nicole Simonavicius, Matthew Ashenden, Antoinette van Weverwijk, Siân Lax, David L. Huso, Christopher D. Buckley, Ivo J. Huijbers, Helen Yarwood, Clare M. Isacke

Blood (2012) 120 (7): 1516–1527.

https://doi.org/10.1182/blood-2011-01-332338

Published: 2012

Includes: Supplemental data

Journal Articles

The Molecular and Cellular Processes of Tumor Cell-Mediated Tumor Angiogenesis and Vasculogenesis,

Quansheng Zhou, MD, PhD, Zhifei Cao, MD, Meimei Bao, Graduate student, Bingxue Shang, Graduate student, Gaochuan Zhang, MD, Yanyan Pan, MD, Jian Tu, Graduate student, Ruifang Liu, Graduate student, Di Yu, Graduate student, Pengda Guo, Graduate student, Ping Yang, Graduate student

Blood (2011) 118 (21): 3267.

https://doi.org/10.1182/blood.V118.21.3267.3267

Published: 2011

Journal Articles

Oncogenic Regulation of Tissue Factor Expression

Janusz W. Rak, MD, PhD, Nathalie Magnus, MSc, Delphine Garnier, PhD, Esterina D’Asti, Maryam Hashemi, BSc, Brian Meehan, BSc, Chloe Milsom, Joanne L Yu, MD, PhD

Blood (2011) 118 (21): SCI-16.

https://doi.org/10.1182/blood.V118.21.SCI-16.SCI-16

Published: 2011

Journal Articles

A Recombinant Antibody to EphA3 for the Treatment of Hematologic Malignancies: Research Update and Interim Phase 1 Study Results

Anne Hagey, M.D., Jeffrey E. Lancet, MD, Varghese Palath, PhD, Andrew H Wei, MBBS, PhD, Martin Lackmann, PhD, Jorge E. Cortes, Andrew Boyd, MD, PhD, Dan Shochat, PhD, Geoffrey Yarranton, PhD, Christopher Bebbington, DPhil., Jonathan A. Leff, MD

Blood (2011) 118 (21): 4893.

https://doi.org/10.1182/blood.V118.21.4893.4893

Published: 2011

Journal Articles

Thrombocytopenia Induced-Tumor Vascular Leakiness Increases Drug Efficacy

Mélanie Demers, Benoit Ho-Tin-Noé, Daphne Schatzberg, B.S., Janie J Yang, Denisa D. Wagner, PhD

Blood (2010) 116 (21): 2105.

https://doi.org/10.1182/blood.V116.21.2105.2105

Published: 2010

NARROW

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

Antisense Oligonucleotide Targeting of Thrombopoietin Synthesis Reduces Platelet Count within the Hemostatic Range and Slows Progression of De Novo Mammary Carcinogenesis in the Mmtv-Pymt Mouse

Highly Multiplexed Imaging Mass Cytometry Allows Visualization of Tumor and Immune Cell Interactions of the Tumor Microenvironment in FFPE Tissue Sections

Regulation of the Tumor Microenvironment By High Molecular Weight Kininogen

Treatment of Hodgkin Lymphoma Xenografts with the Novel PI3K δ/γ Inhibitor RP6530 Suppresses M2 Macrophage Polarization and Results in Potent Antitumor and Antiangiogenic Effects

Relationship of Baseline Tumor Angiogenesis with Kinetics of Inflammatory Markers in DLBCL

Synergistic Induction of Cell Death in Hodgkin Lymphoma Cells By the Novel PI3K Inhibitor RP6530 Combined with Brentuximab Vedotin (SGN-35) through Inhibition of Tumor Angiogenesis

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans

KB004, a Novel Non-Fucosylated Humaneered® Antibody, Targeting EphA3, Is Active and Well Tolerated in a Phase I/II Study of Advanced Hematologic Malignancies

Non Pegylated Liposomal Doxorubicin in Combination with Dexamethasone and Lenalidomide (RMD) Is Active in Advanced MM

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Potent Effects Of The Vascular Disrupting Agent, ASA404 (DMXAA) On The Marrow Microenvironment In Preclinical Human Leukemia and Lymphoma Models

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

ADAMTS13 Expressed In Glioblastoma and Astrocytoma Cells Can Modulate Endothelial Cell Migration

SOX11 Regulates Angiogenesis In Mantle Cell Lymphoma

Pericytes promote selective vessel regression to regulate vascular patterning

The Molecular and Cellular Processes of Tumor Cell-Mediated Tumor Angiogenesis and Vasculogenesis,

Oncogenic Regulation of Tissue Factor Expression

A Recombinant Antibody to EphA3 for the Treatment of Hematologic Malignancies: Research Update and Interim Phase 1 Study Results

Thrombocytopenia Induced-Tumor Vascular Leakiness Increases Drug Efficacy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only